Question 1

Is stem cell therapy FDA approved?

Accepted Answer

Only for a few specific uses. The FDA says its approved stem cell products are cord blood-derived blood-forming cell products for disorders of the blood-forming system. Its approved-products register also lists Ryoncil, a mesenchymal stromal cell therapy approved in December 2024 for steroid-refractory acute GVHD in children, and Omisirge. The FDA warns that most other stem cell, cord blood, Wharton's jelly and exosome products marketed to consumers are not approved.

Question 2

What conditions can stem cell therapy treat?

Accepted Answer

Proven uses are mainly blood and immune system disorders. These are treated with hematopoietic stem cell transplantation, which has been used for more than 50 years, mostly for lymphomas, myeloma and leukemias. Stem cells are also used in some skin and cornea grafts. Regulators have approved a few other products for narrow indications, such as limbal stem cell deficiency in the EU and ALS or knee osteoarthritis in South Korea. Other uses remain experimental.

Question 3

What are the risks of stem cell therapy?

Accepted Answer

The risks depend on the treatment. After a donor-cell (allogeneic) transplant, graft-versus-host disease occurs in about 35–45% of patients with related donors and 60–80% with unrelated donors. Infections are another serious risk. With unapproved products, the FDA has reported blindness, tumor formation, sepsis, neurological events, unwanted immune reactions and cells moving to unintended sites.

Question 4

How do I know if a stem cell clinic is legitimate?

Accepted Answer

Ask for published preclinical studies that independent experts have reviewed, approval from an ethics review board, and authorization from a national regulator such as the FDA, EMA or MFDS. Also ask for a written protocol and a consent form. The ISSCR lists these warning signs: testimonial-based claims, one treatment for many unrelated diseases, an unclear cell source, claims of no risk, and high or hidden costs.

Question 5

Is stem cell therapy legal in South Korea?

Accepted Answer

Yes, within limits. The Ministry of Food and Drug Safety has approved several stem cell products, including Cellgram-AMI, Cartistem, Cupistem and Neuronata-R. Since a February 2025 amendment to Korea's advanced regenerative medicine law, designated institutions may also offer investigational cell therapies to patients with life-threatening, intractable or rare diseases. Each treatment plan needs approval from a central committee, and patients pay the full cost.

Question 6

What should I check before stem cell treatment in Korea?

Accepted Answer

Before stem cell treatment in Korea, confirm whether the specific product or procedure is approved or is an investigational treatment under Korean regulation, check that the institution is licensed and registered to treat foreign patients, ask for the clinical evidence and trial registration, and get costs, risks and follow-up care in writing.

Question 7

What is stem cell therapy used for?

Accepted Answer

The most established use of stem cell therapy is hematopoietic stem cell transplantation for blood cancers and certain immune and blood disorders. Most other uses, including orthopedic, cosmetic and anti-aging treatments, are investigational, and regulators such as the U.S. FDA warn against unapproved products.

Predicate	Value	Source
Entity type	Medical treatment	pending
Most established use	Hematopoietic stem cell transplantation for blood and immune disorders	[1]
Regulator (United States)	U.S. Food and Drug Administration (FDA)	[2]
Regulator (South Korea)	Ministry of Food and Drug Safety (MFDS)	[3]
Typical cost range (Korea)	[PRICE RANGE — pending verified source]	pending

Stem Cell Therapy

Is stem cell therapy FDA approved?

Key facts

Overview

References

Is stem cell therapy FDA approved?

Key facts

Overview

Related entities

Related questions

References